Annual EBITDA
-$8.84 M
+$4.12 M+31.79%
December 31, 2023
Summary
- As of February 7, 2025, ENTX annual EBITDA is -$8.84 million, with the most recent change of +$4.12 million (+31.79%) on December 31, 2023.
- During the last 3 years, ENTX annual EBITDA has risen by +$2.27 million (+20.44%).
- ENTX annual EBITDA is now -140.54% below its all-time high of -$3.67 million, reached on December 31, 2015.
Performance
ENTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.01 M
-$856.00 K-39.74%
September 30, 2024
Summary
- As of February 7, 2025, ENTX quarterly EBITDA is -$3.01 million, with the most recent change of -$856.00 thousand (-39.74%) on September 30, 2024.
- Over the past year, ENTX quarterly EBITDA has dropped by -$961.00 thousand (-46.90%).
- ENTX quarterly EBITDA is now -148.55% below its all-time high of -$1.21 million, reached on December 31, 2016.
Performance
ENTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.16 M
-$638.00 K-7.48%
September 30, 2024
Summary
- As of February 7, 2025, ENTX TTM EBITDA is -$9.16 million, with the most recent change of -$638.00 thousand (-7.48%) on September 30, 2024.
- Over the past year, ENTX TTM EBITDA has dropped by -$477.00 thousand (-5.49%).
- ENTX TTM EBITDA is now -424.20% below its all-time high of -$1.75 million, reached on June 30, 2016.
Performance
ENTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ENTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.8% | -46.9% | -5.5% |
| 3 y3 years | +20.4% | -30.0% | +12.0% |
| 5 y5 years | +18.3% | -30.0% | +12.0% |
ENTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | -54.4% | +26.1% | -7.5% | +36.1% |
| 5 y | 5-year | at high | +31.8% | -54.4% | +26.1% | -7.5% | +36.1% |
| alltime | all time | -140.5% | +31.8% | -148.6% | +31.3% | -424.2% | +36.1% |
Entera Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.01 M(+39.7%) | -$9.16 M(+7.5%) |
| Jun 2024 | - | -$2.15 M(+5.1%) | -$8.53 M(-1.9%) |
| Mar 2024 | - | -$2.05 M(+5.1%) | -$8.69 M(-1.7%) |
| Dec 2023 | -$8.84 M(-31.8%) | -$1.95 M(-17.8%) | -$8.84 M(-11.1%) |
| Sep 2023 | - | -$2.37 M(+2.5%) | -$9.94 M(-4.6%) |
| Jun 2023 | - | -$2.31 M(+5.3%) | -$10.41 M(-8.1%) |
| Mar 2023 | - | -$2.20 M(-28.0%) | -$11.33 M(-12.5%) |
| Dec 2022 | -$12.95 M(+6.5%) | -$3.05 M(+7.1%) | -$12.95 M(-7.3%) |
| Sep 2022 | - | -$2.85 M(-11.9%) | -$13.97 M(-2.5%) |
| Jun 2022 | - | -$3.23 M(-15.3%) | -$14.33 M(+5.0%) |
| Mar 2022 | - | -$3.82 M(-6.3%) | -$13.65 M(+12.2%) |
| Dec 2021 | -$12.16 M(+9.5%) | -$4.07 M(+27.1%) | -$12.16 M(+16.7%) |
| Sep 2021 | - | -$3.21 M(+25.4%) | -$10.42 M(+8.8%) |
| Jun 2021 | - | -$2.56 M(+9.7%) | -$9.58 M(-8.8%) |
| Mar 2021 | - | -$2.33 M(0.0%) | -$10.50 M(-4.7%) |
| Dec 2020 | -$11.11 M | -$2.33 M(-1.5%) | -$11.02 M(-9.2%) |
| Sep 2020 | - | -$2.37 M(-32.0%) | -$12.13 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$3.48 M(+22.2%) | -$12.54 M(+13.7%) |
| Mar 2020 | - | -$2.85 M(-17.3%) | -$11.03 M(-1.7%) |
| Dec 2019 | -$11.22 M(+3.8%) | -$3.44 M(+24.0%) | -$11.22 M(+9.5%) |
| Sep 2019 | - | -$2.78 M(+41.4%) | -$10.24 M(-0.8%) |
| Jun 2019 | - | -$1.96 M(-35.3%) | -$10.32 M(+6.3%) |
| Mar 2019 | - | -$3.04 M(+23.1%) | -$9.71 M(-10.2%) |
| Dec 2018 | -$10.81 M(-4.4%) | -$2.47 M(-13.7%) | -$10.81 M(-15.0%) |
| Sep 2018 | - | -$2.86 M(+111.7%) | -$12.72 M(+0.7%) |
| Jun 2018 | - | -$1.35 M(-67.4%) | -$12.63 M(-11.5%) |
| Mar 2018 | - | -$4.14 M(-5.5%) | -$14.27 M(+40.8%) |
| Dec 2017 | -$11.30 M(+111.9%) | -$4.38 M(+58.2%) | -$10.14 M(+45.4%) |
| Sep 2017 | - | -$2.77 M(-7.6%) | -$6.97 M(+23.8%) |
| Jun 2017 | - | -$2.99 M(+147.2%) | -$5.63 M(+28.4%) |
| Dec 2016 | -$5.33 M(+45.2%) | -$1.21 M(-15.0%) | -$4.38 M(+38.2%) |
| Sep 2016 | - | -$1.43 M(-18.5%) | -$3.17 M(+81.5%) |
| Jun 2016 | - | -$1.75 M | -$1.75 M |
| Dec 2015 | -$3.67 M | - | - |
FAQ
- What is Entera Bio annual EBITDA?
- What is the all time high annual EBITDA for Entera Bio?
- What is Entera Bio annual EBITDA year-on-year change?
- What is Entera Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Entera Bio?
- What is Entera Bio quarterly EBITDA year-on-year change?
- What is Entera Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Entera Bio?
- What is Entera Bio TTM EBITDA year-on-year change?
What is Entera Bio annual EBITDA?
The current annual EBITDA of ENTX is -$8.84 M
What is the all time high annual EBITDA for Entera Bio?
Entera Bio all-time high annual EBITDA is -$3.67 M
What is Entera Bio annual EBITDA year-on-year change?
Over the past year, ENTX annual EBITDA has changed by +$4.12 M (+31.79%)
What is Entera Bio quarterly EBITDA?
The current quarterly EBITDA of ENTX is -$3.01 M
What is the all time high quarterly EBITDA for Entera Bio?
Entera Bio all-time high quarterly EBITDA is -$1.21 M
What is Entera Bio quarterly EBITDA year-on-year change?
Over the past year, ENTX quarterly EBITDA has changed by -$961.00 K (-46.90%)
What is Entera Bio TTM EBITDA?
The current TTM EBITDA of ENTX is -$9.16 M
What is the all time high TTM EBITDA for Entera Bio?
Entera Bio all-time high TTM EBITDA is -$1.75 M
What is Entera Bio TTM EBITDA year-on-year change?
Over the past year, ENTX TTM EBITDA has changed by -$477.00 K (-5.49%)